GSK says RSV vaccine for older adults provides protection over two seasons

GlaxoSmithKline's new clinical trial results suggest seniors may only need to take the pharmaceutical company's RSV shot every other year.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.